Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a phase II study to determine the antitumor activity of Vinorelbine and
Cyclofosfamide association among patients with refractory tumours or in relapse with
rhabdomyosarcomas and other soft tissue tumours, Ewing tumours, osteosarcomas, neuroblastomas
or medulloblastomas.